Schizophrenia Research
Volume 88, Issue 1 , Pages 90-95 , December 2006

High rates of comorbidity are found in childhood-onset schizophrenia

Received 14 February 2006 ,Revised 7 July 2006 ,Accepted 10 July 2006.

References 

  1. Aguilar MC, Gurpegui M, Diaz FJ, de Leon J. Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. Br. J. Psychiatry. 2005;186:215–221
  2. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, D.C: American Psychiatric Association Press; 1994;4
  3. Asarnow JR, Tompson M, Goldstein MJ. Childhood-onset schizophenia: a followup study. Schizo Bull. 1994;20:599–617
  4. Beresford C, Hepburn S, Ross RG. Schizophrenia in preschool children: 2 case reports with longitudinal follow-up for 5.92 and 8.6 years. Clin. Child Psychol. Psychiatry. 2005;10:429–439
  5. Bermanzohn PC, Porto L, Arlow PB, Pollack S, Stronger R, Siris SG. At issue: hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes. Schizophr. Bull. 2000;26:517–525
  6. Biederman J, Faraone SV, Wozniak J, Mick E, Kwon A, Cayton GA, et al. Clinical correlates of bipolar disorder in a large, referred sample of children and adolescents. J. Psychiatr. Res. 2005;39:611–622
  7. Bland RC, Newman SC, Orn H. Schizophrenia: lifetime co-morbidity in a community sample. Acta Psychiatr. Scand. 1987;4:383–391
  8. Bland RX, Newman SC, Orn H. Schizophrenia: lifetime comorbidity in a community sample. Acta Psychiatr. Scand. 1987;75:383–391
  9. Braga RJ, Petrides G, Figueira I. Anxiety disorders in schizophrenia. Compr. Psychiatry. 2004;45:460–468
  10. Bressan RA, Chaves AC, Pilowsky LS, Shirakawa I, Mari JJ. Depressive episodes in stable schizophrenia: critical evaluation of the DSM-IV and ICD-110 diagnostic criteria. Psychiatry Res. 2003;117:47–56
  11. Buckley PF. Substance abuse in schizophrenia: a review. J. Clin. Psychiatry. 1998;59(supplement 3):26–30
  12. Buervenich S, Carmine A, Arvidsson M, Xiang R, Zhiping Z, Sydow O, et al. NURR1 mutations in schizophrenia and manic depressive disorder. Am. J. Med. Genet. 2000;96:813
  13. Campbell M, Small AM, Collins PJ, Friedman E, David R, Genieser N. Levodopa and levoamphetamine: a crossover study in young schizophrenic children. Curr. Ther. Res., Clin. Exp. 1976;19:70–86
  14. Cassano GB, Pini S, Saettoni M, Rucci P, Dell'Osso L. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. J. Clin. Psychiatry. 1998;59:60–68
  15. Cosoff SJ, Hafner RJ. The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder. Aust. N. Z. J. Psychiatry. 1998;32:67–72
  16. Craig T, Hwang MY, Bromet EJ. Obsessive–compulsive and panic symptoms in patients with first-admission psychosis. Am. J. Psychiatry. 2002;159:592–598
  17. deLeon J, Dadvanc M, Canuso C, White AO, Stanilla JK, Simpson GM. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am. J. Psychiatry. 1995;152:453–455
  18. Diwan A, Castine M, Pomerleau CS, Meador-Woodruff JH, Dalack GW. Differential prevalence of cigarette smoking in patients with schizophrenia vs mood disorders. Schizophr. Res. 1998;33:113–118
  19. Eggers C, Bunk D. The long-tem course of childhood-onset schizophrenia: a 42-year followup. Schizo Bull. 1997;23:105–117
  20. Glynn SM, Sussman S. Why patients smoke [Letter]. Hosp. Commun. Psychiatry. 1990;41:1027–1028
  21. Goff DS, Henderson DC, Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am. J. Psychiatry. 1992;149:1189–1194
  22. Goodwin R, Lyons JS, McNally RJ. Panic attacks in schizophrenia. Schizophr. Res. 2002;58:213–220
  23. Goodwin RD, Amador ZF, Malaspina D, Yale SA, Goetz RR, Gorman JM. Anxiety and substance use comorbidity among inpatients with schizophrenia. Schizophr. Res. 2003;61:89–95
  24. Green AI, Canuso CM, Brenner MJ, Wojcik JD. Detection and management of comorbidity in patients with schizophrenia. Psychiatr. Clin. North Am. 2003;26:115–139
  25. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry. 1986;143:993–997
  26. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for affective disorders and schizophrenia for school-age children—present and lifetime version (K-SADS-PL): initial reliability and validity data. J. Am. Acad. Child Adolesc. Psych. 1997;36:980–988
  27. Koreen AR, Siris SG, Chakos M, Alvir J, Mayerhoff D, Lieberman J. Depression in first-episode schizophrenia. Am. J. Psychiatry. 1993;150:1643–1648
  28. Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M, et al. Promotor variants in the á7 nicotinic acetylcholine receptor subunit gene are associated with an inhibitory deficit found in schizophrenia. Arch. Gen. Psychiatry. 2002;59:1085–1090
  29. Levy DL, Smith M, Robinson D, Jody D, Lerner G, Alvir J, et al. Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls. Biol. Psychiatry. 1993;34:507–514
  30. Lieberman JA, Kane JM, Alvir J. Provacative tests with psychostimulant drugs in schizophrenia. Psychopharmacology. 1987;91:415–433
  31. Marder SR, Fenton W. Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr. Res. 2004;72:5–9
  32. Martin RL, Cloninger CR, Guze SB, Clayton PJ. Frequency and differential diagnosis of depressive syndromes in schizophrenia. J. Clin. Psychiatry. 1985;46:9–13
  33. Maziade M, Gingras N, Rodrigue C, Bouchard S, Cardinal A, Gauthier B, et al. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. I: Nosology, sex, and age of onset. Br. J. Psychiatry. 1996;169:361–370
  34. McKenna K, Gordon CT, Lenane M, Kaysen D, Fahey K, Rapoport JL. Looking for childhood-onset schizophrenia: the first 71 cases screened. J. Am. Academy Child Adolesc. Psychiatry. 1994;33:636–644
  35. Nechmad A, Ratzoni G, Poyurovsky M, Meged S, Avidan G, Fuchs C, et al. Obsessive–compulsive disorder in adolescent schizophrenia patients. Am. J. Psychiatry. 2003;160:1002–1004
  36. Nicolson R, Lenane M, Hamburger SD, Fernandez T, Bedwell J, Rapoport JL. Lessons from childhood-onset schizophrenia. Brain Res. Brain Res. Rev. 2000;31:147–156
  37. O'Farrell TJ, Connors GJ, Upper D. Addictive behaviors among hospitalized psychiatric patients. Addict. Behav. 1983;8:329–333
  38. Pallanti S, Quercioli L, Hollander E. Social anxiety in outpatients with schizophrenia: a relevant cause of disability. Am. J. Psychiatry. 2004;161:53–58
  39. Rabinowitz J, Bromet EJ, Lavelle J, Carlson G, Kovasznay B, Schwartz JE. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychol. Med. 1998;28:1411–1419
  40. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidty of mental disorders with alcohol and other drug abuse. J. Am. Med. Assoc. 1990;264:2511–2518
  41. Rogeness GA, Macedo CA. Therapeutic response of a schizophrenic boy to a methylphenidate–chlorpromazine combination. Am. J. Psychiatry. 1983;140:932–933
  42. Ross RG. Early expression of a pathophysiological feature of schizophrenia: saccadic intrusions into smooth pursuit eye movements in school-age children vulnerable to schizophrenia. J. Am. Acad. Child Adolesc. Psych. 2003;42:468–476
  43. Ross RG, Olincy A, Harris JG, Radant AD, Hawkins M, Adler LE, et al. Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset schizophrenia. Am. J. Med. Genet. 1999;88:188–199
  44. Ross RG, Novins D, Farley GK, Adler LE. A one-year open-label trial of olanzapine in school-age children with schizophrenia. J. Child Adolesc. Psychopharmacol. 2003;13:301–309
  45. Ross RG, Schaeffer J, Compagnon N, Heinlein S, Beresford C, Farley G. Creating school-age versions of semistructured interviews for the prodrome to schizophrenia: lessons from case reviews. Schizophr. Bull. 2003;29:729–736
  46. Ross RG, Heinlein S, Zerbe GO, Radant A. Saccadic eye movement deficit identifies cognitive deficits in children with schizophrenia, but not in unaffected child relatives. J. Child Psychol. Psychiatry. 2005;46:1354–1362
  47. Schaeffer J, Ross RG. Childhood-onset schizophrenia: premorbid and prodromal diagnosis and treatment histories. J. Am. Acad. Child Adolesc. Psych. 2002;41:538–545
  48. Sharma RP, Javaid JI, Pandey GN, Janicak PG, Davis JM. Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients. Biol. Psychiatry. 1991;30:459–466
  49. Strakowski SM, Tohen M, Stoll AL, Gaedda GL, Mayer PV, Kolbrener ML, et al. Comorbidity in psychosis at first hospitalization. Am. J. Psychiatry. 1993;150:752–757
  50. Tibbo P, Swainson J, Chue P, LeMelledo JM. Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia. Depress. Anxiety. 2003;17:65–72
  51. Tossell JW, Greenstein DK, Davidson AL, Job SB, Gochman P, Lenane M, et al. Stimulant drug treatment in childhood-onset schizophrenia with comorbid ADHD: an open-label case series. J. Child Adolesc. Psychopharmacol. 2004;14:448–454
  52. Werry JS, McClellan JM, Chard L. Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: a clinical and outcome study. J. Am. Academy Child. Adolesc. Psychiatry. 1991;30:457–465

PII: S0920-9964(06)00321-5

doi: 10.1016/j.schres.2006.07.006

Schizophrenia Research
Volume 88, Issue 1 , Pages 90-95 , December 2006

Article Tools